Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications identification endonuclease domain encoded r2 other site specific non long terminal
… patients with eosinophilic esophagitis with high versus non-high all-cause costs: an analysis of insurance claims …
… that parents would prefer the Tula in-office procedure as long as its success rate was at least 68%. The performance …
… and their lives, with a focus on the impact of cancer and long-term illness on children and families, in addition to … Technology Assessment International (HTAi), and disease specific conferences. She spent 2 years working in large and …
… biologic products. RTI-HS is in the trenches with CBER and other partners in the BEST System to address FDA regulatory …
… K, Grant L, Barry R, Huang L, McDade C , Wilson M . Non-vaccine serotype population-level trends for invasive …
RTI receives Cigna Healthy Workforce Designation ™ Share on: March 3, 2023 Image Cigna has selected nonprofit research institute RTI International, parent company of RTI Health Solutions, as a recipient of their silver level Healthy Workforce Designation …
… and vaccines, including post-authorization safety and other regulatory studies. She has worked extensively in multi-site collaborations with data from electronic health records … develop methods and data capabilities to conduct these and other postmarketing safety studies. Dr. Kawai received her …
… analysis. Alternatively, they can be a component of other larger projects such as regulatory submissions (e.g. …
… bonus opportunities and a robust recognition program. Other benefits include a competitive range of family …
… of treatment effectiveness in patients with advanced non-small cell lung cancer (aNSCLC) with MET exon 14 skipping …